Thesis (Sc. D.)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2009.Cataloged from PDF version of thesis.Includes bibliographical references.In a collaborative effort with the Massachusetts Eye and Ear Infirmary, Draper Laboratory is developing an implantable microfluidic drug delivery system for long-term treatment of inner ear disorders and prevention of sensorineural hearing loss. This versatile device is envisioned to deliver multiple therapies and control the sequence and rate of drug dosing. Such a system could have an immediate application in the treatment of ototoxic and inflammatory conditions affecting the inner ear, including autoimmune inner ear disease and cisplatin-induced ototoxicity. Current efforts...
Thesis: Ph. D., Harvard-MIT Program in Health Sciences and Technology, 2014.Cataloged from PDF versi...
The mammalian cochlea is one of the least accessible organs for drug delivery. Systemic administrati...
The cochlear implant (CI) represents, for almost 25 years now, the gold standard in the treatment of...
In a collaborative effort with the Massachusetts Eye and Ear Infirmary, Draper Laboratory is develop...
Cochlear implants (CIs) are the preferred treatment for patients with moderate to profound sensorine...
The usage of 1D and 3D models to simulate drug transport through the inner ear is a prominent method...
© 2013 Dr. Elisha Bonnie King (nee Thomas)Also known as: Thomas, Elisha BonnieThere is growing inter...
AbstractFor many years, drug delivery to the inner ear has been a challenge to physicians in the tre...
This research describes a unique, effective and inexpensive delivery system to provide discrete quan...
A proof of concept to microfabricate an electrode array suitable for use with cochlear implants was ...
Long-term drug delivery to the inner ear for neuroprotection might improve the outcome for hearing d...
Intra-cochlear drug delivery may represent a key issue in cochlear implant (CI) success in the futur...
The sense of hearing is essential for permitting human beings to interact with the environment, and ...
Hypothesis: Cochlear fluid pharmacokinetics can be better represented by three-dimensional (3D) fini...
Anti-inflammatory drugs can minimize the trauma and inflammation in the inner ear caused by cochlear...
Thesis: Ph. D., Harvard-MIT Program in Health Sciences and Technology, 2014.Cataloged from PDF versi...
The mammalian cochlea is one of the least accessible organs for drug delivery. Systemic administrati...
The cochlear implant (CI) represents, for almost 25 years now, the gold standard in the treatment of...
In a collaborative effort with the Massachusetts Eye and Ear Infirmary, Draper Laboratory is develop...
Cochlear implants (CIs) are the preferred treatment for patients with moderate to profound sensorine...
The usage of 1D and 3D models to simulate drug transport through the inner ear is a prominent method...
© 2013 Dr. Elisha Bonnie King (nee Thomas)Also known as: Thomas, Elisha BonnieThere is growing inter...
AbstractFor many years, drug delivery to the inner ear has been a challenge to physicians in the tre...
This research describes a unique, effective and inexpensive delivery system to provide discrete quan...
A proof of concept to microfabricate an electrode array suitable for use with cochlear implants was ...
Long-term drug delivery to the inner ear for neuroprotection might improve the outcome for hearing d...
Intra-cochlear drug delivery may represent a key issue in cochlear implant (CI) success in the futur...
The sense of hearing is essential for permitting human beings to interact with the environment, and ...
Hypothesis: Cochlear fluid pharmacokinetics can be better represented by three-dimensional (3D) fini...
Anti-inflammatory drugs can minimize the trauma and inflammation in the inner ear caused by cochlear...
Thesis: Ph. D., Harvard-MIT Program in Health Sciences and Technology, 2014.Cataloged from PDF versi...
The mammalian cochlea is one of the least accessible organs for drug delivery. Systemic administrati...
The cochlear implant (CI) represents, for almost 25 years now, the gold standard in the treatment of...